Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION)
Purpose. We sought to explore the effects of intravitreal injection of the Rho-kinase inhibitor Y-27632 in a rodent model of nonarteritic anterior ischemic optic neuropathy (rAION). Methods. The rAION model was established by using laser-induced photoactivation of intravenously administered Rose Ben...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/1485425 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546959257239552 |
|---|---|
| author | Zuohuizi Yi Liao Chen Xiaoling Wang Changzheng Chen Yiqiao Xing |
| author_facet | Zuohuizi Yi Liao Chen Xiaoling Wang Changzheng Chen Yiqiao Xing |
| author_sort | Zuohuizi Yi |
| collection | DOAJ |
| description | Purpose. We sought to explore the effects of intravitreal injection of the Rho-kinase inhibitor Y-27632 in a rodent model of nonarteritic anterior ischemic optic neuropathy (rAION). Methods. The rAION model was established by using laser-induced photoactivation of intravenously administered Rose Bengal in rats. The rats received intravitreal injections of Y-27632 or PBS 1, 3, and 6 days after rAION induction. Optical coherence tomography (OCT) was performed at 2 days and 4 weeks after induction. Visual evoked potential (VEP) was used to evaluate the visual function at 4 weeks. Brn3a immunofluorescence staining of surviving RGCs and apoptosis assays of RGCs were performed at 4 weeks. Results. Optic nerve head (ONH) width was significantly reduced in the Y-27632 group compared with that in the PBS group at 2 days after induction (p<0.05). At 4 weeks, the P1 amplitude of flash-VEP (FVEP) in the Y-27632 group was significantly higher than that of the PBS group (p<0.05). The RGC densities in the central and midperipheral retinas in the Y-27632 group were significantly higher than those in the PBS group (p<0.05). Furthermore, there was a significant decrease in apoptotic RGCs in the Y-27632 group than in the PBS group (p<0.05). Conclusions. Intravitreal injection of Y-27632 had neuroprotective effects on ONH edema, RGC survival, and visual function preservation in rAION. |
| format | Article |
| id | doaj-art-8e747d1a8c3e4afab6a250828e0f1c7b |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-8e747d1a8c3e4afab6a250828e0f1c7b2025-02-03T06:46:31ZengWileyJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/14854251485425Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION)Zuohuizi Yi0Liao Chen1Xiaoling Wang2Changzheng Chen3Yiqiao Xing4Eye Center, Wuhan University Renmin Hospital, Wuhan, ChinaDepartment of Ultrasound Imaging, Wuhan University Renmin Hospital, Wuhan, ChinaEye Center, Wuhan University Renmin Hospital, Wuhan, ChinaEye Center, Wuhan University Renmin Hospital, Wuhan, ChinaEye Center, Wuhan University Renmin Hospital, Wuhan, ChinaPurpose. We sought to explore the effects of intravitreal injection of the Rho-kinase inhibitor Y-27632 in a rodent model of nonarteritic anterior ischemic optic neuropathy (rAION). Methods. The rAION model was established by using laser-induced photoactivation of intravenously administered Rose Bengal in rats. The rats received intravitreal injections of Y-27632 or PBS 1, 3, and 6 days after rAION induction. Optical coherence tomography (OCT) was performed at 2 days and 4 weeks after induction. Visual evoked potential (VEP) was used to evaluate the visual function at 4 weeks. Brn3a immunofluorescence staining of surviving RGCs and apoptosis assays of RGCs were performed at 4 weeks. Results. Optic nerve head (ONH) width was significantly reduced in the Y-27632 group compared with that in the PBS group at 2 days after induction (p<0.05). At 4 weeks, the P1 amplitude of flash-VEP (FVEP) in the Y-27632 group was significantly higher than that of the PBS group (p<0.05). The RGC densities in the central and midperipheral retinas in the Y-27632 group were significantly higher than those in the PBS group (p<0.05). Furthermore, there was a significant decrease in apoptotic RGCs in the Y-27632 group than in the PBS group (p<0.05). Conclusions. Intravitreal injection of Y-27632 had neuroprotective effects on ONH edema, RGC survival, and visual function preservation in rAION.http://dx.doi.org/10.1155/2020/1485425 |
| spellingShingle | Zuohuizi Yi Liao Chen Xiaoling Wang Changzheng Chen Yiqiao Xing Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION) Journal of Ophthalmology |
| title | Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION) |
| title_full | Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION) |
| title_fullStr | Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION) |
| title_full_unstemmed | Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION) |
| title_short | Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION) |
| title_sort | protective effects of intravitreal injection of the rho kinase inhibitor y 27632 in a rodent model of nonarteritic anterior ischemic optic neuropathy raion |
| url | http://dx.doi.org/10.1155/2020/1485425 |
| work_keys_str_mv | AT zuohuiziyi protectiveeffectsofintravitrealinjectionoftherhokinaseinhibitory27632inarodentmodelofnonarteriticanteriorischemicopticneuropathyraion AT liaochen protectiveeffectsofintravitrealinjectionoftherhokinaseinhibitory27632inarodentmodelofnonarteriticanteriorischemicopticneuropathyraion AT xiaolingwang protectiveeffectsofintravitrealinjectionoftherhokinaseinhibitory27632inarodentmodelofnonarteriticanteriorischemicopticneuropathyraion AT changzhengchen protectiveeffectsofintravitrealinjectionoftherhokinaseinhibitory27632inarodentmodelofnonarteriticanteriorischemicopticneuropathyraion AT yiqiaoxing protectiveeffectsofintravitrealinjectionoftherhokinaseinhibitory27632inarodentmodelofnonarteriticanteriorischemicopticneuropathyraion |